S&P 500   4,966.81 (-0.88%)
DOW   37,990.25 (+0.57%)
QQQ   414.07 (-2.21%)
AAPL   165.08 (-1.17%)
MSFT   399.12 (-1.27%)
META   477.67 (-4.81%)
GOOGL   153.59 (-1.55%)
AMZN   173.95 (-2.94%)
TSLA   146.60 (-2.22%)
NVDA   764.87 (-9.67%)
AMD   146.22 (-5.71%)
NIO   3.80 (-5.00%)
BABA   69.02 (+0.20%)
T   16.47 (+0.86%)
F   12.09 (+0.25%)
MU   106.31 (-5.02%)
GE   148.30 (-3.03%)
CGC   8.02 (+2.43%)
DIS   112.11 (-0.28%)
AMC   3.14 (+7.53%)
PFE   25.96 (+2.24%)
PYPL   61.87 (-0.37%)
XOM   119.88 (+1.15%)
S&P 500   4,966.81 (-0.88%)
DOW   37,990.25 (+0.57%)
QQQ   414.07 (-2.21%)
AAPL   165.08 (-1.17%)
MSFT   399.12 (-1.27%)
META   477.67 (-4.81%)
GOOGL   153.59 (-1.55%)
AMZN   173.95 (-2.94%)
TSLA   146.60 (-2.22%)
NVDA   764.87 (-9.67%)
AMD   146.22 (-5.71%)
NIO   3.80 (-5.00%)
BABA   69.02 (+0.20%)
T   16.47 (+0.86%)
F   12.09 (+0.25%)
MU   106.31 (-5.02%)
GE   148.30 (-3.03%)
CGC   8.02 (+2.43%)
DIS   112.11 (-0.28%)
AMC   3.14 (+7.53%)
PFE   25.96 (+2.24%)
PYPL   61.87 (-0.37%)
XOM   119.88 (+1.15%)
S&P 500   4,966.81 (-0.88%)
DOW   37,990.25 (+0.57%)
QQQ   414.07 (-2.21%)
AAPL   165.08 (-1.17%)
MSFT   399.12 (-1.27%)
META   477.67 (-4.81%)
GOOGL   153.59 (-1.55%)
AMZN   173.95 (-2.94%)
TSLA   146.60 (-2.22%)
NVDA   764.87 (-9.67%)
AMD   146.22 (-5.71%)
NIO   3.80 (-5.00%)
BABA   69.02 (+0.20%)
T   16.47 (+0.86%)
F   12.09 (+0.25%)
MU   106.31 (-5.02%)
GE   148.30 (-3.03%)
CGC   8.02 (+2.43%)
DIS   112.11 (-0.28%)
AMC   3.14 (+7.53%)
PFE   25.96 (+2.24%)
PYPL   61.87 (-0.37%)
XOM   119.88 (+1.15%)
S&P 500   4,966.81 (-0.88%)
DOW   37,990.25 (+0.57%)
QQQ   414.07 (-2.21%)
AAPL   165.08 (-1.17%)
MSFT   399.12 (-1.27%)
META   477.67 (-4.81%)
GOOGL   153.59 (-1.55%)
AMZN   173.95 (-2.94%)
TSLA   146.60 (-2.22%)
NVDA   764.87 (-9.67%)
AMD   146.22 (-5.71%)
NIO   3.80 (-5.00%)
BABA   69.02 (+0.20%)
T   16.47 (+0.86%)
F   12.09 (+0.25%)
MU   106.31 (-5.02%)
GE   148.30 (-3.03%)
CGC   8.02 (+2.43%)
DIS   112.11 (-0.28%)
AMC   3.14 (+7.53%)
PFE   25.96 (+2.24%)
PYPL   61.87 (-0.37%)
XOM   119.88 (+1.15%)

HCW Biologics (HCWB) Institutional Ownership

$1.52
-0.14 (-8.43%)
(As of 12:22 PM ET)

Institutional Ownership Changes (13F Filings) for HCW Biologics (NASDAQ:HCWB)

Current
Institutional Ownership
Percentage
2.96%
Number of
Institutional Buyers
(last 12 months)
4
Total
Institutional Inflows
(last 12 months)
$384.52K
Number of
Institutional Sellers
(last 12 months)
0
Get HCWB Insider Trade Alerts

Want to know when executives and insiders are buying or selling HCW Biologics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

HCWB Institutional Buying and Selling by Quarter

HCW Biologics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/9/2024Avantax Planning Partners Inc.179,541$220K0.0%N/A0.499%
12/18/2023Vanguard Group Inc.204,619$389K0.0%+9.4%0.569%
8/11/2023BlackRock Inc.49,687$108K0.0%+12.8%0.138%
5/12/2023HighTower Advisors LLC354,869$497K0.0%+31.5%0.989%
2/14/2023Two Sigma Investments LP32,240$62K0.0%-15.2%0.090%
2/9/2023HighTower Advisors LLC269,869$517K0.0%+19.6%0.752%
11/15/2022Vanguard Group Inc.95,392$218K0.0%+9.8%0.266%
5/12/2022BlackRock Inc.39,583$108K0.0%+136.8%0.111%
5/12/2022HighTower Advisors LLC215,598$588K0.0%+2,056.0%0.602%
11/15/2021HighTower Advisors LLC14,000$45K0.0%N/A0.039%
(Data available from 1/1/2016 forward)

HCWB Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of HCWB shares?

During the previous two years, the following institutional investors and hedge funds held shares of HCW Biologics shares: HighTower Advisors LLC ($497K), Vanguard Group Inc. ($389K), Avantax Planning Partners Inc. ($220K), and BlackRock Inc. ($108K), Two Sigma Investments LP ($62K).Learn more on HCWB's institutional investors.

What percentage of HCW Biologics stock is owned by institutional investors?

2.96% of HCW Biologics stock is owned by institutional investors. Learn more on HCWB's institutional investor holdings.

Which institutional investors have been buying HCW Biologics stock?

The following institutional investors have purchased HCW Biologics stock in the last 24 months: HighTower Advisors LLC ($334.87K), Avantax Planning Partners Inc. ($179.54K), BlackRock Inc. ($28.49K), and Vanguard Group Inc. ($26.02K).

How much institutional buying is happening at HCW Biologics?

Institutional investors have bought a total of 568,922 shares in the last 24 months. This purchase volume represents approximately $1.11M in transactions.

Which HCW Biologics major shareholders have been selling company stock?

The following institutional investors have sold HCW Biologics stock in the last 24 months: Two Sigma Investments LP ($5.80K).

How much institutional selling is happening at HCW Biologics?

Institutional investors have sold a total of 5,800 shares in the last 24 months. This volume of shares sold represents approximately $11.11K in transactions.


This page (NASDAQ:HCWB) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners